15 years of revenue, profit, cash flow and balance-sheet history through FY2026,
from SEC filings — with a computed, factual read of the trend.
Updated Overview →
Growth & profitability
Revenue has declined 11.4% per year over the past 5 years.
Operating margin has expanded, at 10.9% in the latest year.
Financial health
Total debt ($117M) exceeds cash ($26M); net debt is $91M.
Total debt has grown in line with revenue (-8.9% vs -11.4% per year).
Operating income covered interest expense 1.2× in the latest year.
Total debt is 4.1× EBITDA.
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Return on equity & assets (ROE / ROA)
ROEROA
Free cash flow (CFO − capex)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key annual figures
FY
Revenue
Net income
Gross M
Op M
ROE
ROA
FCF
Total debt
Cash
2026
$224M
$7M
0.0%
10.9%
3.6%
1.3%
$11M
$117M
$26M
2025
$210M
$124M
0.0%
9.5%
66.6%
20.6%
$12M
$111M
$17M
2024
$203M
$91M
0.0%
10.3%
160.4%
17.2%
-$2M
$100M
$10M
2023
$233M
-$7M
0.0%
3.8%
20.1%
-1.2%
-$8M
$177M
$10M
2022
$276M
-$86M
0.0%
-10.5%
277.4%
-11.2%
-$44M
$180M
$17M
2021
$412M
-$113M
0.0%
-23.0%
—
-11.4%
-$111M
$187M
$19M
2020
$670M
-$171M
0.0%
-21.7%
—
-12.8%
-$124M
$178M
$114M
2019
$1.1B
-$14M
0.0%
-2.1%
—
-2.1%
-$49M
$90M
$70M
2018
$1.2B
$6M
0.0%
-0.4%
—
0.8%
-$27M
$90M
$110M
2017
—
-$19M
—
—
—
-1.8%
$32M
$121M
$171M
2016
—
-$11M
—
—
—
-1.1%
$33M
$120M
$147M
2015
—
-$34M
—
—
—
-2.9%
$56M
$120M
$212M
2014
—
-$139M
—
—
—
-9.8%
$67M
$294M
$379M
2013
—
$31M
—
—
—
2.2%
-$36M
—
$201M
2012
—
-$114M
—
—
—
-7.3%
$68M
$288M
$112M
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Return on equity & assets (ROE / ROA)
ROEROA
Free cash flow (CFO − capex, quarterly)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key quarterly figures
Quarter
Revenue
Net income
Gross M
Op M
ROE
ROA
FCF
Total debt
Cash
Jun '26
$56M
$4M
0.0%
11.8%
2.3%
0.8%
$4M
$117M
$26M
Mar '26
$52M
$735000
0.0%
10.9%
0.4%
0.1%
$5M
$115M
$23M
Dec '25
$57M
$456000
0.0%
10.8%
0.2%
0.1%
$891000
$113M
$18M
Sep '25
$59M
$1M
0.0%
10.0%
0.7%
0.2%
$2M
$111M
$17M
Jun '25
$60M
$116M
0.0%
12.1%
62.8%
19.4%
$6M
$111M
$17M
Mar '25
$57M
$250000
0.0%
8.8%
0.4%
0.0%
$6M
$112M
$13M
Dec '24
$47M
$8M
0.0%
11.8%
11.5%
1.4%
$2M
$112M
$10M
Sep '24
$46M
-$853000
0.0%
4.6%
-1.5%
-0.2%
-$1M
$95M
$6M
Jun '24
$49M
$91M
0.0%
9.3%
160.6%
17.2%
$5M
$100M
$10M
Mar '24
$49M
-$2M
0.0%
8.3%
—
-0.4%
-$326000
$180M
$6M
Dec '23
$51M
$997000
0.0%
9.4%
—
0.2%
-$4M
$182M
$7M
Sep '23
$53M
$1M
0.0%
13.9%
—
0.2%
-$3M
$180M
$9M
Jun '23
$56M
-$5M
0.0%
6.4%
13.1%
-0.8%
$434000
$177M
$10M
Mar '23
$56M
-$2M
0.0%
3.6%
—
-0.3%
-$2M
$175M
$9M
Dec '22
$60M
-$2M
0.0%
1.2%
—
-0.4%
-$2M
$175M
$9M
Sep '22
$62M
$1M
0.0%
4.0%
—
0.2%
-$5M
$172M
$10M
Jun '22
$66M
-$43M
0.0%
-2.0%
137.7%
-5.5%
-$5M
$180M
$17M
Mar '22
$64M
-$28M
0.0%
-34.8%
—
-3.2%
-$11M
$0
$26M
Dec '21
$69M
-$5M
0.0%
-0.7%
—
-0.5%
-$13M
$194M
$35M
Sep '21
$77M
-$10M
0.0%
-6.4%
—
-1.1%
-$14M
$196M
$46M
Valuation over time
How the market has priced RGS against its own fundamentals since 2023-03 —
each month-end's share price set against the most recent annual filing, so the multiple moves
as price runs ahead of (or behind) earnings. Split-adjusted.
The price-to-earnings ratio has risen from 10.2× (Jun '26) to 10.7× (Nov '26).
The price-to-sales ratio has risen from 0.0× (Mar '23) to 0.3× (Nov '26).
Price / earnings (P/E)
P/E
Price / sales (P/S)
P/S
Frequently asked questions
Is RGS growing its revenue and profit?
Over the past 5 years, REGIS CORP's revenue has declined 11.4% per year. These are computed facts, not advice.
How much debt does RGS have?
As of FY2026, REGIS CORP reported $117M of total debt against $26M of cash; operating income covered interest expense 1.2×.
What is RGS's profit margin?
In FY2026, gross margin was —, operating margin 10.9%, and net margin 3.1%.
What is RGS's P/E ratio?
REGIS CORP's P/E (TTM) is 10.74 as of the 2026-11-02 close — market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year, the same figure as on the RGS stock page. The valuation chart above sets each month-end's price against the latest annual net income instead, so its latest point (about 10.7× as of Nov '26) can differ. These are computed facts, not advice.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), split-adjusted; price return — dividends not reinvested ·
growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price
against the latest annual filing. Informational only — not investment advice.